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Abstract 
Pseudomonas aeruginosa is an opportunistic human pathogen affecting cystic fibrosis (CF) 
patients and immunocompromised individuals contributing significantly to morbidity and 
mortality.  Once infected with P. aeruginosa, patients are chronically colonized and unable to 
clear the infection even with antimicrobial treatment.  P. aeruginosa is inherently resistant to 
many antimicrobials which has encouraged the hunt for novel potential therapeutics.  Recently, 
P. aeruginosa isolates obtained from the same CF patient were shown to interact antagonistically 
where secreted signals from one isolate decreased protease production by another isolate.  This 
antagonistic interaction also decreased the virulence of the virulent P. aeruginosa isolate.  The 
purpose of this study was to determine if P. aeruginosa isolates from a variety of patients in 
three different age groups (under 13, between 13 and 18, and above 18) would respond to the 
antagonistic signals.  Two antagonistic signal producing P. aeruginosa isolates (14672 and 
14651) were co-cultured with P. aeruginosa isolates obtained from various patients.  After P. 
aeruginosa cultures are grown and mixed they are spotted onto skim milk plates to test for the 
levels of protease production.  Protease production is measured by a zone of clearing around the 
bacterial culture.  The mixed cultures are then compared to individual strains also spotted on the 
skim milk plates.  This method was used to test P. aeruginosa isolates from all age groups and 
isolates from all groups did respond to the antagonistic signals. These results suggest that P. 
aeruginosa from a wide range of patients responds to the antagonistic signal, indicating this 
signal may have potential as a future therapeutic agent for CF patients. 
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Introduction 
Cystic Fibrosis 
Approximately 30,000 children, adolescents, and adults are afflicted with cystic fibrosis (CF) in 
the United States. CF is the most common lethal autosomal recessive genetic disorder among 
Caucasians, appearing in about 1 in 2,500 births (Pier, 1985). In 1989 a molecular basis was 
provided for the disease. The gene responsible for CF has been located on chromosome 7 and 
encodes a protein known as cystic fibrosis transmembrane conductance regulator (CFTR) 
(Kerem et al., 1989). A vast range of mutations on this gene can be responsible for the disease 
(Tsui, 1992). Evidence shows that CFTR functions as a chloride channel. CF epithelia have 
abnormally low chloride conductance across the apical membrane and as a consequence the 
surfaces become dehydrated, the mucous becomes viscous and bacteria are not easily cleared, 
resulting in chronic infection (Guggino, 1999). CF is often diagnosed by the age of two and is 
caused by the production of a faulty protein in the pancreas that causes the body to produce 
abnormally thick and profuse mucus. This hyperproduction of mucus leads to a buildup of thick 
mucus  in the patient’s lung which provides an ample environment for the growth of pathogens 
entering through the respiratory tract. CF patients are predisposed to severe lung infections, 
which ultimately prove fatal for 80% to 95% of CF patients by the age of 50 (Pier et al., 1996).  
Pseudomonas aeruginosa  
P. aeruginosa is a Gram-negative bacterium with a versatile metabolism. Although P. 
aeruginosa is ubiquitous environmentally, P. aeruginosa is an opportunistic human pathogen, as 
it normally does not affect healthy individuals but often infects immunocompromised 
individuals. The pathogen has been isolated from burn victims, surgical patients, CF patients, 
cancer or bone marrow transplant patients, as well as AIDS patients (Driscoll, Brody, & Kollef, 
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2007). The cornerstone of P. aeruginosa’s virulence is its inherent resistance to a wide variety of 
antibiotics and disinfectants (Hancock, 1998). These characteristics prove treatment of these 
infections to be exceedingly difficult. This enhanced resistance is multifactorial resulting from 
the presence of multidrug efflux pumps (Kohler et al., 1997), both beta-lactamases (Hancock & 
Woodruff, 1988), and decreased permeability of the outer membrane(Hancock, 1998). P. 
aeruginosa’s vast virulence characteristics aid to the range of infections it is able to cause. In 
addition to these cellular virulence characteristics, P. aeruginosa also produces extracellular 
virulence factors that enhance the organism’s pathogenesis. These extracellular factors include 
exotoxin A, exoenzyme S, elastase, proteases, rhamnolipids, siderophores, gelatinase, lipase, and 
phospholipase C (Woods & Sokol, 1986). These virulence factors enable P. aeruginosa to 
manipulate a host environment, enhancing its ability to survive. Proteases produced by P. 
aeruginosa have the ability to destroy host proteins and tissues during the infection process and 
aid greatly to the pathogenesis of the microorganism (Galloway, 1991).    
P. aeruginosa  has a social repertoire consisting of interactions that include biofilm formation 
(O'Toole, Kaplan, & Kolter, 2000) and quorum sensing (Manefield & Turner, 2002). Quorum 
sensing regulates virulence factor production in many strains of P. aeruginosa.  P. aeruginosa  is 
known to upregulate  its virulence within the biofilm. Organisms forming biofilms can undergo 
profound changes during their transition from free-living organisms to cells that are part of a 
complex, surface-attached community (O'Toole et al., 2000). These changes are reflected in new 
phenotypic characteristics developed by P. aeruginosa in response to a variety of environmental 
signals within the CF lung (O'Toole et al., 2000). Small signaling molecules are produced by 
individual bacteria within the community and are recognized by other community members 
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(Fuqua, Winans, & Greenberg, 1994). The concentration of the signals within the environment 
can regulate gene expression and the production of many virulence factors (Fuqua et al., 1994).  
Cystic fibrosis and Pseudomonas aeruginosa  
Not only is P. aeruginosa a difficult pathogen to treat, it is known to undergo pathoadaptive 
mutations to modify gene expression within the niche of the CF lung. Infections by P. 
aeruginosa are unique in that they adapt to the CF lung, it acquires loss-of-function mutations 
that decrease virulence factor production (Jain et al., 2004). Pseudomonas isolates from early 
infections are similar to environmental isolates in their phenotype; however as the infection 
prolongs, isolates become more resistant to antibiotics and are frequently mucoid (Govan & 
Harris, 1986). Once a mucoid infection has initiated, it becomes more difficult to treat due to the 
biofilm produced during growth of the pathogen (Henry, Mellis, & Petrovic, 1992). Treatments 
involving long term use of antibiotics often render P. aeruginosa to become multi drug resistant 
(Lyczak, Cannon, & Pier, 2000). Resistant characteristics are often not observed in the initial 
colonization of a patient; however, increasingly appear through the course of infection.  
The CF lung is known to be a polymicrobial community, especially as the patient matures (Bittar 
et al., 2008). Considering the nature of the CF microbial community and social interactions 
among P. aeruginosa within, studying the isolates in a pure form provides a poor representation 
of the environment within the patient’s lung. CF P. aeruginosa  isolates from sub-populations 
display a variability in virulence as well as diversity in virulence factor production between 
isolates within the same sub-population as well as between sub-populations (Lutter, Faria, Rabin, 
& Storey, 2008). Isolates from the same patient show a wide range of diversity suggesting the 
harsh environment of the CF lung may not in fact be selecting for a single phenotype, but for 
multiple phenotypes that work in conjunction (Lutter et al., 2008). It has been previously shown 
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Strain 14650 
Strain 14673 
Strains 14673/14672 
Strain 14650/14651 
Skim milk agar (protease) 
Figure 1: Illustrated action of 14651 and 14672 antagonistic signals. The 
top figure shows isolates from the same patient (14672 and 14673). When 
the two cultures are mixed, there is a significant decrease in protease 
production by strain 14673.The bottom figure illustrates the same action, 
within isolates from a different patient. Strain 14650 produces a large 
amount of proteases in a pure culture; however, this production is shut 
down when mixed with signal 14651. 
that certain combinations of CF isolates result in decreased lethality of a P. aeruginosa infection 
in a D. melanogaster infection, which correlates to decreased production of protease by the 
virulent P. aeruginosa isolate (Lutter et al., 2008).  
This project focuses on the interactions among P. aeruginosa living within the CF patient’s 
respiratory tract. Novel antagonistic signals produced by P. aeruginosa variants (14651 and 
14672) found within the CF lung have been identified and serve as the basis for this project. The 
supernatant of P. aeruginosa CF isolates 14651and 14672 separately decrease the virulence of 
other responsive P. aeruginosa strains (Lutter et al., 2008). These antagonistic signals cause 
reduced production of protease, a well-known virulence factor of P. aeruginosa (Driscoll et al., 
2007) as seen in co-culture experiments (Figure 1; (Lutter et al., 2008). Mixed infections 
between 14651 or 14672 with other P. aeruginosa CF isolates in the D. melanogaster infection 
model resulted in increased fly survival compared to individual infections with highly virulent 
strains (Lutter et al., 2008).  This 
reduction of a virulent stain’s 
lethality suggests that these 
novel antagonistic signals may 
have the potential to be 
developed in the future as an 
alternate therapeutic target to 
decrease the severity of 
infections. It is interesting 
to note that the strains 
producing the antagonistic 
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signals themselves do not respond to the signal. The antagonistic signals only seems to affect 
other isolates. To determine if the signals produced by these strains (14651 and 14672) do indeed 
have therapeutic potential, it must first be shown that it can target P. aeruginosa CF isolates from 
multiple patients and in different age groups.  Demonstrated in this project is the response of P. 
aeruginosa isolates from all age groups to the antagonistic signal of isolate 14651 and 14672.  
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Figure 1: Schematic of 
cultures spotted on 
protease plates.  Each 
isolate and co-culture were 
spotted 3x per plate 
Methods 
P. aeruginosa strain 14651 and 14672  along with CF sputa isolates from teen, child, and adult 
patients obtained from the Cystic Fibrosis Clinic in Oklahoma City were cultured separately 
overnight in 96 well-blocks in brain heart infusion broth. From cryostock, 96 well blocks of CF 
patient P. aeruginosa  isolates are stamped using a 48 pin replicator into 1.5 mL of  BHI broth 
and placed in 37°
C
 shaker/incubator overnight. P. aeruginosa strain 
14651was cultured in 50 mL of BHI broth and also placed in 37°
C
 
shaker/incubator overnight. To observe modified protease 
production in a mixed infection, the antagonistic strain (14651 or 
14672) was plated in parallel with a patient culture and the mixing 
of the two. In each experiment, 14672 or 14651 acted as an internal 
control since we know these isolates do not respond to their own 
signal. These separate cultures were mixed at equal OD600 and 
spotted onto a skim milk protease plate to measure protease production of each culture (Sokol, 
Ohman, & Iglewski, 1979). Protease plates are made with a dialyzed solution from of 9.25 grams 
of BHI broth powder in 25 mL of Nano Water. The solution is allowed to dialyze overnight in a 
500mL graduated cylinder with 500 mL of Nano Water. The dialysate is added to 9.25 grams of 
agar and 250 mL of water which is then autoclaved.  Fifteen grams of skim milk powder is 
separately mixed with 250 mL of Nano Water, then autoclaved on the same cycle. The two 
solutions are mixed after autoclaving. Autoclaving the two media in separate containers helps to 
prevent burning of the skim milk. The media is poured into petri dishes of 15mL aliquots into.   
Fifty µL of the patient culture was mixed with 50 µL of P. aeruginosa strain 14651 or 14672 in a 
96 well plate.  Strain 14651 or 14672 is diluted 1:10 with BHI broth to set an equal OD600 to the 
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patient culture. The strains were spotted onto skim milk plates as demonstrated in Figure 2. Each 
culture is spotted in triplicate in 3 µL aliquots in triplicate.    
Plates are incubated for 24 hours before recording results by measuring the zone of clearing from 
the edge of the bacterial culture to the edge of the zone of clearing using a hand ruler. Each 
individual isolate as well as the control strains (14651 or 14672) were independently measured. 
The data collected represents the actual zone of clearing for each isolate or strain tested. 
Proteases produced by the bacterial culture degrade casein in the skim milk plates which results 
in the zone of clearing. Decrease in protease production was analyzed and plotted using Prism 3 
GraphPad. These methods were repeated on multiple patient isolates from all age groups (child, 
teen, and adult). Data of protease production was statistically analyzed using Prism3 software 
with a One-Way ANOVA test and a Newman-Keuls Posttest to compare all pairs of columns. 
Statistically significant differences were determined by a P value <0.005. Statistically significant 
decreases are notated with an asterisk on each graph.  
This method of testing protease production of CF patient isolates is repeated with a survey of 
patients in all age groups. Patient sputa samples testing include 3 adults: Patient 31314a (age 28), 
patient 32014b (age 41), patient 61214c (age 22); 1 adolescent: patient 32014a (age 16); and 1 
child: patient 22714c (age 12). A sampling of isolates from each patient was selected and tested 
using the above methods.  
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Results and Discussion 
Protease production of isolates from adult patients is shown in Figures 3 and 4.  
Figure 3 demonstrates the effects on protease production by CF isolates from adult patients when 
co-cultured with antagonistic isolate 14672. Many isolates from patient 31314a (depicted in 
Figure3A) respond to the 14672 signal in co-culture. From this patient, all protease producing 
isolates tested show response to the signal. In contrast patient 32014b (depicted in figure 3B) 
shows fewer responders to the 14672 signal. We do observe two isolates from this patient that 
abolish their protease production when co-cultured; however the majority of isolates do not 
respond to the signal produced by 14672.  Isolates from patient 61214c moderately respond to 
the 14672 signal.  
Figure 4 depicts the response of the isolates from the same 3 adult patients, but now to the 14651 
antagonistic signal. Patient 31314a isolates, although extensively responsive to 14672, are less 
responsive to 14651; however, we do see multiple responding isolates from patient 31314a to 
14651. A variety of isolates from patient 32014b respond to the 14651 signal. Isolates from adult 
patient 61214c also shows wide response to the 14651 signal. When comparing the responding 
isolates of the same patient exposed to the two unique signals, we observe a difference in the 
isolates that respond with decreased protease production.  Specifically, isolates that respond to 
the signal from 14651 do not necessarily respond to the signal from 14672 and vice versa. This 
provides us with preliminary evidence that these two antagonistic strains are different in the 
method of action.  
We continue to observe this pattern of responding isolates to the 14651 and 14672 signals from 
adolescents and child patients, as well as the diversity in the response to 14651 or 14672.  
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Figures 5 and 6 illustrate the response of isolates from adolescent and child isolate to both 14651 
and 14672 signals.  
Response to the signal produced by 14672 is shown in Figure 5. Isolates of child patient 22714c 
shows few responding isolates; however, there are two statistically significant responding 
isolates within this child. Isolates from adolescent patient 32014a respond widely to the 14672 
signal, similar to the response we saw in adult patients. When we look at the 14651 response in 
isolates from the same child and adolescent patients, we see that both age groups have a fair 
amount of responding isolates. Isolates from child patient 22714c show response to the 14651 
signal when co-cultured, as well as isolates of adolescent patient 32014a. 
 Overall, we observed P. aeruginosa isolates that respond to the antagonistic signal in each age 
group; however the response of the isolates varied. Our goal was to see that there were at least a 
few responding isolates within each patient to the antagonistic signal. The hope is to utilize this 
antagonistic signal as a potential therapeutic in the future for CF patients. A decrease in the 
amount proteases produced by P. aeruginosa within the patient’s lungs has the potential to 
decrease the severity of an infection and pulmonary decline in CF patients. In order for this 
future therapeutic to be of value to all patients in the CF community it was necessary to verify 
that P. aeruginosa  isolated from patients in all age groups have the potential to respond with 
decreased protease production to antagonistic signals.  As the P. aeruginosa are exposed to the 
signal, their protease production is reduced; however, it does not appear to kill the bacteria as P. 
aeruginosa growth is still observed on the skim milk plates. The antagonistic signals are 
inhibiting growth of the P. aeruginosa strains, only decreasing virulence. If used in treatment, 
this signal would be used in combination with existing antimicrobial therapies to decrease the 
severity of infection.   Reducing the severity of infections and exacerbations would decrease the 
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rate of pulmonary decline, thus increasing the quality of life for CF patients and may enable 
patients to live longer. 
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Figure 3: Response of P. aeruginosa isolates from adult patient to antagonistic P. aeruginosa strain 
14672. Statistically significant decreases in protease production are indicated with an asterisk. Responding 
isolates are observed in within each patient.  
(A): patient 31314a, 28 year old male, exhibits responding isolates to the 14651 signal when co-cultured 
with 1A,1B,1C,1D,1E,1G,1H, 2A,2B,2C,2D,2F,2G,2H,3G4A, and 4B 
(B): patient 32014b, 41 year old male, exhibits responding isolates to the 14651 signal when co-cultured 
with 11C, 11E, and 11E.  
(C): patient 61214c, 22 year old male, exhibits responding isolates to the 14651 signal when co-cultured 
with 1C, 1D, 2A, 2D, 2E, 2F, 2G, 2H, 4G, and 4H.  
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Figure 4: Response P. aeruginosa isolates from adult patient to antagonistic P. aeruginosa 
strain 14651. Statistically significant decreases in protease production are indicated with an 
asterisk. Responding isolates are observed in within each patient.  
(A): patient 31314a, 28 year old male, exhibits responding isolates to the 14672 signal when co-
cultured with 1E, 2C, 2D, and 2E. 
(B): patient 32014b, 41 year old male, exhibits responding isolates to the 14672 signal when co-
cultured with 1C, 1E,1F,1G,1H,2A,2B,2C,2D,2F,2G,and 2H. 
(C): patient 61214c, 22 year old male, exhibits responding isolates to the 14672 signal when co-
cultured with 1C, 1D, 2A, 2D, 2E, 2F, 2G, and 2H.  
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Figure 5: Response of P. aeruginosa isolates from child (A) and adolescent (B) patients to 
antagonistic P. aeruginosa strain 14672. Statistically significant decreases in protease 
production are indicated with an asterisk. Responding isolates are observed within each patient.  
(A): patient 22714c, 12 year old male, exhibits responding isolates to the 14672 signal when co-
cultured with 2B and 2C. 
(B): patient 32014a, 16 year old male, exhibits responding isolates to the 14672 signal when co-
cultured with 1B, 1C, 2D, 2G, 2H, 3C, 3D, 3E, and 3F.  
 
 
 
17 
22714c/14651
1
4
6
5
1
1
A
1
A
/1
4
6
5
1
1
B
1
B
/1
4
6
5
1
1
C
1
C
/1
4
6
5
1
1
D
1
D
/1
4
6
5
1
1
E
1
E
/1
4
6
5
1
1
F
1
F
/1
4
6
5
1
1
G
1
G
/1
4
6
5
1
1
H
1
H
/1
4
6
5
1
2
A
2
A
/1
4
6
5
1
2
B
2
B
/1
4
6
5
1
2
C
2
C
/1
4
6
5
10.0
2.5
5.0
7.5
10.0
Zone Size
*
*
**
Z
o
n
e
 S
iz
e
 (
m
m
)
32014a/14651
1
4
6
5
1
2
A
2
A
/1
4
6
5
1
2
B
2
B
/1
4
6
5
1
2
C
2
C
/1
4
6
5
1
2
D
2
D
/1
4
6
5
1
2
E
2
E
/1
4
6
5
1
2
F
2
F
/1
4
6
5
1
2
G
2
G
/1
4
6
5
1
2
H
2
H
/1
4
6
5
1
1
A
1
A
/1
4
6
5
1
1
E
IE
/1
4
6
5
1
1
F
1
F
/1
4
6
5
1
1
G
1
G
/1
4
6
5
1
1
H
1
H
/1
4
6
5
1
3
A
3
A
/1
4
6
5
1
3
B
3
B
/1
4
6
5
1
3
C
3
C
/1
4
6
5
1
3
D
3
D
/1
4
6
5
1
3
E
3
E
/1
4
6
5
1
3
F
3
F
/1
4
6
5
1
3
G
3
G
/1
4
6
5
1
3
H
3
H
/1
4
6
5
1
0.0
2.5
5.0
7.5
10.0
Zone Size
*
*
*
* *
* *
*
*
*
*
* *
*
*
Culture
Z
o
n
e
 S
iz
e
 (
m
m
)
B
A  
 
 
 
 
 
 
 
 
 
 
Figure 6: Response of P. aeruginosa isolates from child (A) and adolescent (B) patients to 
antagonistic P. aeruginosa strain 14651. Statistically significant decreases in protease 
production are indicated with an asterisk. Responding isolates are observed within each patient.  
(A): patient 22714c, 12 year old male, exhibits responding isolates to the 14672 signal when co-
cultured with 1B, 1D, 1E, 1F, 1G, 2A, 2B, and 2C. 
(B): patient 32014a, 16 year old male, exhibits responding isolates to the 14672 signal when co-
cultured with 2A, 2B, 2C, 2D, 2E, 2F, 2G, 1E, 1F, 1G, 1H, 3D, 3F, 3G, and 3H.  
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Conclusions and Future Directions 
In conclusion, CF isolate 14651 and 14672 both produce a signal that decreases the protease 
production by other P. aeruginosa CF isolates. We’ve found responding isolates from patients of 
every age group that respond to the 14651 and 14672 antagonistic signal. There is variability in 
the response of CF isolates to the signal within a patient and between patients. The reduction of 
protease production suggests that these novel antagonistic signals reduce the virulence of certain 
P. aeruginosa isolates and therefore has the potential to be developed in the future as an alternate 
therapeutic target to decrease the severity of infections. In future studies, the genomes of both 
14651 and 14672 will be sequenced to determine what genes make these two variants unique 
from other P. aeruginosa isolates. Gene expression studies of lasA and lasB protease genes using 
qRT-PCR should be utilized to determine the alteration of virulent stains when exposed to 14651 
and 14672 signaling.  
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